Company Introduction

innovate New & Next
We help chart the next century.

Since its establishment in 1984, inno.N has tapped into the belief that its business was also helping chart the nation’s future. This belief has served and continues to serve the company well, as it has grown into one of the leading pharmaceutical firms in the nation.

Since its establishment in 1984, inno.N has gained competitiveness in the businesses of prescription drugs, active pharmaceutical ingredients, health supplements and beauty products.

Drawing on the company’s experience and knowhow in developing novel drugs, inno.N succeeded in launching ‘K-CAB’, the 30th novel drug to be developed and registered in Korea, to great acclaim. Building on this success, inno.N remains committed to growing into a global bio health company built on outstanding products and technologies that bring us closer to a healthier future.

Business Overview

inno.N operates the prescription drugs, health, and beauty businesses and is making a leap into a global pharmaceutical company through active exports and partnerships.

Key businesses

inno.N is targeting the global pharmaceutical&bio market beyond Korea with its portfolio of various chronic disease drugs. We are developing and supplying excellent drugs that improve the quality of life based on the potential that has been grown through blockbusters by developing K-CAB, Korea's 30th new drug, for the treatment of gastroesophageal reflux disease.

In the area of Health & Beauty, inno.N continues to be active. Examples include 'CONDITION', which has been the undisputed No. 1 market share since pioneering the hangover cure market in 1992, 'HUTGAESOO', a steady seller in the healthy RTD market, 'TEALOG', a zero-calorie ice tea, and 'BEWANTS', a slow-aging skincare brand. inno.N is solidifying its position as a healthcare partner with the life cycle of its customers.